We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
UK Gupta, anticounterfeiting industry veteran, founder, and former President of the Authentication Solution Providers Association (ASPA) and CMD, Holostik India passed away on June 1, 2021.
London-headquartered AMO Pharma has announced the launch of a ‘pivotal’ phase III study of its congenital myotonic dystrophy (CDM1) candidate AMO-02 (tideglusib).
Suboptimal diet accounts for 18.2 percent of all cardiometabolic disease (CMD) costs in the United States, according to a study published online December in PLOS Medicine.
Collaborative Medicinal Development, LLC) ("CMD"), a clinical stage biopharmaceutical company with a portfolio of candidates for treatment of neurological and neuropsychiatric diseases.